Xencor

Xencor is a clinical-stage biotechnology company focused on discovering and developing innovative biotherapeutics, particularly antibodies and proteins with enhanced functionality. Their proprietary XmAb® protein engineering platform allows them to precisely modify the Fc domain of antibodies, the "stem" of the antibody structure, resulting in improved potency, half-life, and stability. This technology has enabled Xencor to build a deep pipeline of drug candidates for treating cancer, autoimmune disorders, and infectious diseases.

Xencor's approach is driven by a plug-and-play strategy where their optimized Fc domains can be integrated into nearly any antibody. This flexibility has fostered numerous partnerships with pharmaceutical companies like Alexion, Incyte, Genentech, and Amgen, who are utilizing Xencor's technology to develop their own proprietary antibody therapeutics. Their diverse portfolio of Fc domains, including bispecific, immune inhibitor, cytotoxic, and Xtend variations, underscores their commitment to pushing the boundaries of antibody drug development.

Xencor offers a flexible work environment for its employees. They provide options for telecommuting and flexible work schedules, demonstrating their commitment to work-life balance.

Xencor offers a comprehensive benefits package designed to support employees' physical, financial, and emotional well-being. Benefits include medical, dental, and vision insurance, as well as life, short-term, and long-term disability insurance. Financial benefits include annual cash bonuses, equity grants, tuition reimbursement, an employee stock purchase plan, a 401(k) with company matching, healthcare and dependent care flexible spending accounts. Employees also enjoy personal paid leave, holidays, mental wellness and employee assistance programs, telecommuting and flexible work schedule options, and pet insurance.

Xencor, a clinical-stage biotechnology company, is driven by a mission to improve patient outcomes and quality of life by discovering and developing superior biotherapeutics. Their pioneering XmAb® protein engineering platform enables the creation of antibodies and other proteins with enhanced functions, targeting life-threatening and debilitating diseases, primarily in the areas of cancer, autoimmune disorders, and infectious diseases.

Xencor promotes a culture of innovation, scientific rigor, and collaboration. They value new ideas, flexibility, and a willingness to take risks. Their employees are encouraged to challenge themselves and each other, fostering a dynamic and rewarding work environment. This environment is designed to motivate and reward employees, with a competitive total rewards package and a focus on attracting the best and most qualified candidates in their respective fields.

Xencor prioritizes building a diverse and inclusive workplace, recognizing that a variety of perspectives and backgrounds contribute to their success. They actively recruit and hire individuals from diverse demographics, fostering a culture of inclusivity that values new ideas and flexibility. Xencor also offers competitive benefits and a work environment that challenges, motivates, and rewards employees, striving to create a sense of belonging and opportunity for all.